The infertility drugs market is poised to grow by USD 1.05 billion during 2021-2025, progressing at a CAGR of almost 5% during the forecast period. 

Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.

Download: Technavio’s Analysis on Market characteristics

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing lifestyle diseases.

The infertility drugs market analysis includes product segment and geography landscape. This study identifies the rising trend of late parenthood as one of the prime reasons driving the infertility drugs market growth during the next few years.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The infertility drugs market covers the following areas:

Infertility Drugs Market Sizing
Infertility Drugs Market Forecast
Infertility Drugs Market Analysis

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • Bayer AG
  • Ferring Pharmaceuticals AS
  • GlaxoSmithKline Plc
  • Merck and Co. Inc.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA

Related Reports on Health Care Include:

IVF Devices Market by End-user and Geography – Forecast and Analysis 2020-2024

Sperm Bank Market by Service and Geography – Forecast and Analysis 2020-2024

Assisted Reproductive Technology Market by Application and Geography – Forecast and Analysis 2020-2024

IVF Devices and Consumables Market by Product and Geography – Forecast and Analysis 2020-2024

Key Topics Covered:

Executive Summary

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 – 2025

Five Forces Analysis

  • Five forces analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Hormone-based therapy – Market size and forecast 2020-2025
  • Others – Market size and forecast 2020-2025
  • Market opportunity by Product

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America – Market size and forecast 2020-2025
  • Europe – Market size and forecast 2020-2025
  • Asia – Market size and forecast 2020-2025
  • ROW – Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • AbbVie Inc.
  • Bayer AG
  • Ferring Pharmaceuticals AS
  • GlaxoSmithKline Plc
  • Merck and Co. Inc.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports. 
Technavio’s SUBSCRIPTION platform

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Report: https://www.technavio.com/talk-to-us?report=IRTNTR41375

SOURCE Technavio

Related Links

https://www.technavio.com/talk-to-us?report=IRTNTR41375

Author

Generosa Delgado has been a health writer for Press Daily since 2018. Previously, she was a health and medical writer for The Los Angeles Times. Generosa has experience working as a freelance journalist since 2016, and before that as a staff writer for Health Magazine.